rdf:type |
|
lifeskim:mentions |
umls-concept:C0017337,
umls-concept:C0042769,
umls-concept:C0205473,
umls-concept:C0208973,
umls-concept:C0220847,
umls-concept:C0444669,
umls-concept:C1517892,
umls-concept:C1519323,
umls-concept:C1704666,
umls-concept:C1979963,
umls-concept:C2003903,
umls-concept:C2700116
|
pubmed:issue |
1
|
pubmed:dateCreated |
2011-2-1
|
pubmed:abstractText |
The biological role of the protein encoded by the alternative open reading frame (core+1/ARF) of the Hepatitis C virus (HCV) genome remains elusive, as does the significance of the production of corresponding antibodies in HCV infection. We investigated the prevalence of anti-core and anti-core+1/ARFP antibodies in HCV-positive blood donors from Cambodia, using peptide and recombinant protein-based ELISAs. We detected unusual serological profiles in 3 out of 58 HCV positive plasma of genotype 1a. These patients were negative for anti-core antibodies by commercial and peptide-based assays using C-terminal fragments of core but reacted by Western Blot with full-length core protein. All three patients had high levels of anti-core+1/ARFP antibodies. Cloning of the cDNA that corresponds to the core-coding region from these sera resulted in the expression of both core and core+1/ARFP in mammalian cells. The core protein exhibited high amino-acid homology with a consensus HCV1a sequence. However, 10 identical synonymous mutations were found, and 7 were located in the aa(99-124) region of core. All mutations concerned the third base of a codon, and 5/10 represented a T>C mutation. Prediction analyses of the RNA secondary structure revealed conformational changes within the stem-loop region that contains the core+1/ARFP internal AUG initiator at position 85/87. Using the luciferase tagging approach, we showed that core+1/ARFP expression is more efficient from such a sequence than from the prototype HCV1a RNA. We provide additional evidence of the existence of core+1/ARFP in vivo and new data concerning expression of HCV core protein. We show that HCV patients who do not produce normal anti-core antibodies have unusually high levels of anti-core+1/ARFP and harbour several identical synonymous mutations in the core and core+1/ARFP coding region that result in major changes in predicted RNA structure. Such HCV variants may favour core+1/ARFP production during HCV infection.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-11350035,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-11447125,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-11884417,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-12160863,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-12810869,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-12874283,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-12952944,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-15269371,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-15367612,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-15382175,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-15732002,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-15755749,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-15867491,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-16122679,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-16168082,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-1660488,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-16876117,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-17047346,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-17185560,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-17299041,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-17436105,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-17651444,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-17671755,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-17678898,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-17700029,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-18243391,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-18632960,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-18971267,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-19009259,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-19054148,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-19129450,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-19350656,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-19548320,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-20067524,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-2170712,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-7542272,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-8583911,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-8991942,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-9367361,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21283512-9466746
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1932-6203
|
pubmed:author |
pubmed-author:BudkowskaAgataA,
pubmed-author:DalagiorgouGeenaG,
pubmed-author:GeorgopoulouUraniaU,
pubmed-author:HormSrey VisethSV,
pubmed-author:KakkanasAthanassiosA,
pubmed-author:KalininaOlgaO,
pubmed-author:MaillardPatrickP,
pubmed-author:MartinotMichelleM,
pubmed-author:MavromaraPenelopeP,
pubmed-author:NerrienetEricE,
pubmed-author:SallAmadou AlphaAA,
pubmed-author:VassilakiNikiN
|
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e15871
|
pubmed:meshHeading |
pubmed-meshheading:21283512-Hepacivirus,
pubmed-meshheading:21283512-Hepatitis C,
pubmed-meshheading:21283512-Hepatitis C Antibodies,
pubmed-meshheading:21283512-Humans,
pubmed-meshheading:21283512-Mutation,
pubmed-meshheading:21283512-Nucleic Acid Conformation,
pubmed-meshheading:21283512-Open Reading Frames,
pubmed-meshheading:21283512-Polymorphism, Single Nucleotide,
pubmed-meshheading:21283512-RNA, Viral,
pubmed-meshheading:21283512-Viral Core Proteins
|
pubmed:year |
2011
|
pubmed:articleTitle |
Synonymous mutations in the core gene are linked to unusual serological profile in hepatitis C virus infection.
|
pubmed:affiliation |
Institut Pasteur, Hépacivirus et Immunité Innée, CNRS URA 3015, Paris, France. agata.budkowska@pasteur.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|